Near-critical fluid micronization of stabilized vaccines, antibiotics and anti-virals

Journal of Supercritical Fluids

Volumn 42, Issue 3 SPEC. ISS., 2007, Pages 385-391

  Sievers, R E ^a,b   Quinn, B P ^a   Cape, S P ^a,b   Searles, J A ^a   Braun, C S ^b   Bhagwat, P ^a,b   Rebits, L G ^a,b   McAdams, D H ^b   Burger, J L ^b   Best, J A ^b   Lindsay, L ^c   Hernandez, M T ^c   Kisich, K O ^d   Iacovangelo, T ^e   Kristensen, D ^e   Chen, D ^e  

^a Aktiv Dry LLC   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c UCB 450   (United States)

^d NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^e PATH   (United States)

Author keywords

Aerosol delivery; Antibiotic; Supercritical CO2; Vaccine

Indexed keywords

CARBON DIOXIDE; DRYING; FLOW OF FLUIDS; PRODUCT DEVELOPMENT; PROTEINS; SUPERCRITICAL FLUIDS; VACCINES;

AEROSOL DELIVERY; BUBBLE DRYER; FLUID MICRONIZATION; MASS MEDIAN AERODYNAMIC DIAMETER (MMAD); NEBULIZATION; SUPERCRITICAL CO2;

ANTIBIOTICS;

EID: 34447262087     PISSN: 08968446     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.supflu.2007.03.001     Document Type: Article

References (39)

1. Diminsky D., Moav N., Gorecki M., and Barenholz Y. Physical, chemical and immunological stability of CHO-derived hepatitis B surface antigen (HBsAg) particles. Vaccine 18 (1999) 3-17
2. Edstam J.S., Dulmaa N., Nymadawa P., Rinchin A., Khulan J., and Kimball A.M. Comparison of hepatitis B vaccine coverage and effectiveness among urban and rural Mongolian 2-year-olds. Prev. Med. 34 (2002) 207-214
3. Edstam J.S., Dulmaa N., Tsendjav O., Dambasuren B., and Densmaa B. Exposure of hepatitis B vaccine to freezing temperatures during transport to rural health centers in Mongolia. Prev. Med. 39 (2004) 384-388
4. Klotz S.A., Normand R., and Silberman R. Hepatitis-B vaccine in healthy hospital employees. Infect. Control Hosp. Epidemiol. 7 (1986) 365-369
5. Maa Y.F., Zhao L., Payne L.G., and Chen D.X. Stabilization of alum-adjuvanted vaccine dry powder formulations: mechanism and application. J. Pharm. Sci. 92 (2003) 319-332
6. Mclean A.A., and Shaw R. Hepatitis-B virus-vaccine. Ann. Intern. Med. 97 (1982) 451
7. Nelson C.M., Wibisono H., Purwanto H., Mansyur I., Moniaga V., and Widjaya A. Hepatitis B vaccine freezing in the Indonesian cold chain: evidence and solutions. Bull. World Health Organ. 82 (2004) 99-105
8. R.E. Sievers, S.P. Sellers, J.F. Carpenter, Supercritical fluid-assisted nebulization and bubble drying, Chinese Patent 00811293.2 (2005).
9. R.E. Sievers, S.P. Sellers, J.F. Carpenter, Supercritical fluid-assisted nebulization and bubble drying, European Patent US2004067259 (2004).
10. R.E. Sievers, S.P. Sellers, J.F. Carpenter, Supercritical fluid-assisted nebulization and bubble drying, US Patent 6,630,121 (2003).
11. R.E. Sievers, S.P. Sellers, J.F. Carpenter, Supercritical fluid-assisted nebulization and bubble drying, World International Property Organization WO0075281 (2000).
12. R.E. Sievers, U. Karst, Methods and apparatus for fine particle formation, European Patent US2002018815 (2002).
13. R.E. Sievers, U. Karst, Methods and apparatus for fine particle formation, European Patent 1160018 (2001).
14. R.E. Sievers, U. Karst, Methods and apparatus for fine particle formation, 2000, US Patent 6095134.
15. R.E. Sievers, U. Karst, Methods for fine particle formation, European Patent US5639441 (1997).
16. R.E. Sievers, U. Karst, Methods for fine particle formation, US Patent 5639441 (1997).
17. Villa J.A., Sievers R.E., and Huang E.T.S. Bubble drying to form fine particles from solutes in aqueous solutions. In: Perrut M., and Reverchon E. (Eds). 7th Meeting on Supercritical Fluids: Particle Design-Materials and Natural Products Processing. I.S.A.S.F., Antibes/Juan-Les-Pins (France) (2000) 83-88
18. Villa J., Huang E., Cape S., and Sievers R. Synthesis of composite microparticles with a mixing cross. Aerosol Sci. Technol. 39 (2005) 473-484
19. Sievers R.E., Villa J.A., Cape S.P., Alargov D.K., Rinner L., Huang E.T.S., and Quinn B.P. Synthesis and coating respirable particles with a low volume mixing cross or tee. In: Dalby R.N., Byron P.R., Peart J., Suman J.D., and Farr S.J. (Eds). Respiratory Drug Delivery IX (2004), Davis Healthcare International Publishing, LLC (River Grove, IL), Palm Desert, CA (USA) 765-767
20. Sievers R.E., Milewski P.D., Xu C.Y., Karst U., Rusic-Pavletic J., Kusek K.D., Mandal T., Andersen W.C., Stoldt C.R., Schaefer J.D., and Miles B.A. Supercritical fluid emulsions with aqueous solutions for forming fine particles of pharmaceuticals and metal oxides. In: Perrut M., and Subra P. (Eds). 5th Meeting on Supercritical Fluids. Nice, France (1998) 273-274
21. Sievers R.E., Milewski P.D., Sellers S.P., Miles B.A., Korte B.J., Kusek K.D., Clark G.S., Mioskowski B., and Villa J.A. Supercritical and near-critical carbon dioxide assisted low-temperature bubble drying. Ind. Eng. Chem. Res. 39 (2000) 4831-4836
22. 2-assisted methods for the production and pulmonary administration of pharmaceutical aerosols. J. Aerosol Sci. 29 (1998) S1271-S1272
23. 2-assisted nebulization for the production and administration of drugs. J. Aerosol Sci. 27 (1996) S497-S498
24. Sievers R.E., Karst U., Milewski P.D., Sellers S.P., Miles B.A., Schaefer J.D., Stoldt C.R., and Xu C.Y. Formation of aqueous small droplet aerosols assisted by supercritical carbon dioxide. Aerosol Sci. Technol. 30 (1999) 3-15
25. Sievers R.E., Huang E.T.S., Villa J.A., Walsh T.R., Meresman H.V., Liang C.D., and Cape S.P. Rapid gentle drying using dense carbon dioxide to form fine dry powders. In: Dalby R.N., Byron P.R., Peart J., and Farr S.J. (Eds). Respiratory Drug Delivery VIII (2002), Davis Horwood International Publishing, Limited, (Godalming, Surrey, UK), Tucson, AZ (USA) 675-677
26. Sievers R.E., Huang E.T.S., Villa J.A., and Walsh T.R. CAN-BD process for rapidly forming and drying fine particles. In: Besnard M., and Cansell F. (Eds). 8th Meeting on Supercritical Fluids: Chemical Reactivity and Material Processing in Supercritical Fluids. I.S.A.S.F., Bordeaux (France) (2002) 73-78
27. Sievers R.E., Huang E.T.S., Villa J.A., Kawamoto J.K., Evans M.M., and Brauer P.R. Low-temperature manufacturing of fine pharmaceutical powders with supercritical fluid aerosolization in a Bubble Dryer®. Pure Appl. Chem. 73 (2001) 1299-1303
28. Sievers R.E., Huang E.T.S., Villa J.A., Engling G., and Brauer P.R. Micronization of water-soluble or alcohol-soluble pharmaceuticals and model compounds with a low-temperature Bubble Dryer®. J. Supercrit. Fluids 26 (2003) 9-16
29. Sievers R.E., Huang E.T.S., and Villa J.A. Generation of fine particles by a bubble dryer. J. Aerosol Med. 14 (2001) 390
30. 2 at near ambient conditions. J. Aerosol Med. 16 (2003) 213
31. 2-assisted aerosolization. J. Pharm. Sci. 90 (2001) 785-797
32. Lagalante A.F., Hansen B.N., Bruno T.J., and Sievers R.E. Solubilities of copper(II) and chromium(III) β-diketonates in supercritical carbon dioxide. Inorg. Chem. 34 (1995) 5781-5785
33. Hybertson B.M., Repine J.E., Beehler C.J., Rutledge S., Lagalante A.F., and Sievers R.E. Pulmonary drug delivery of fine aerosol particles from supercritical fluids. J. Aerosol Med. 6 (1993) 275-286
34. Xu C.Y., Sievers R.E., Karst U., Watkins B.A., Karbiwnyk C.M., Andersen W.C., Schaefer J.D., and Stoldt C.R. Supercritical carbon dioxide assisted aerosolization for thin film deposition, fine powder generation, and drug delivery. In: Anastas P.T., and Williamson T.C. (Eds). Green Chemistry: Frontiers in Benign Chemical Synthesis and Processes (1998), Oxford University Press, Oxford 312-335
35. Huang E.T.S., Chang H.Y., Cape S.P., Rinner L., Quinn B.P., and Sievers R.E. Nanoparticle and microparticle generation with super- or near-critical carbon dioxide. 6th International Symposium on Supercritical Fluids. Versailles, France (2003) 1695-1700
36. Huang E.T.S., Chang H.-Y., Liang C.D., and Sievers R.E. Fine Particle Pharmaceutical Manufacturing using Dense Carbon Dioxide Mixed with Aqueous or Alcoholic Solutions (2003), American Chemical Society, Washington, DC
37. ®, International Congress for Particle Technology, PARTEC 2004, Nuremberg, Germany, 2004.
38. Albrecht P., Herrmann K., and Burns G.R. Role of virus-strain in conventional and enhanced measles plaque neutralization test. J. Virol. Methods 3 (1981) 251-260
39. Heifets L. MIC as a quantitative measurement of the susceptibility of mycobacterium-avium strains to 7 antituberculosis drugs. Antimicrob. Agents Chemother. 32 (1988) 1131-1136